Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Citryll Raises €85m Series B Co-led by JnJ & Forbion & NVF (2024-12-09)
> Financing co-led by Johnson & Johnson Innovation – JJDC, Inc., Forbion and Novartis Venture Fund > Lead first-in-class product candidate, monoclonal antibody CIT-013, to be advanced into two Phase 2a studies Citryll, a biotech company pioneering a trans...
Formycon: MS Pharma to Market Stelara Biosimilar in MENA (2024-12-09)
Formycon AG (FSE: FYB, Prime Standard) and MS Pharma jointly announce that they have entered into a licensing and supply agreement for the commercialization of FYB202, Formycon’s Biosimilar to Stelara®1 (ustekinumab), in the Middle East and North Africa (“MENA...
HTGF Appoints Achim Plum as Managing Director (2024-12-09)
Dr. Achim Plum is to become Managing Director of High-Tech Gründerfonds (HTGF) on 1 January 2025, joining Romy Schnelle and Dr. Alex von Frankenberg on the management team. Dr. Plum, who holds a PhD in genetics, was appointed to the role by the HTGF Investor Advis...
Michael Grosse to Succeed Joachim Kreuzburg as Sartorius CEO (2024-12-06)
Grosse to take over as Group CEO on July 1, 2025 At its meeting today, the Supervisory Board of Sartorius AG appointed Dr. Michael Grosse Chief Executive Officer of Sartorius. He will take over this position on July 1, 2025, from Dr. Joachim Kreuzburg, who wil...
Eckert & Ziegler amd Ariceum Sign Global Supply Agreement (2024-12-05)
Eckert & Ziegler, one of the world’s largest providers of isotopes for medical, scientific and industrial use, and Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to...
IonOpticks: Custom Chromatography Columns for Biognosys (2024-12-05)
Today, IonOpticks, a world leading provider of chromatography solutions, and Biognosys, a global leader in mass spectrometry-based proteomics contract research services, announce a long-term supply agreement. Under the agreement, IonOpticks will supply Biognosys wi...
Newcells Biotech Secures £1.2m from Existing Investors (2024-12-05)
> Funding will support ongoing expansion and technological innovation for targeted solutions to accelerate drug discovery and clinical translation, and reduce reliance on animal testing > Dr. Mark Carnegie-Brown appointed as Chairman of the Board of Directors ...
Abselion (HexagonFab): £6.6m Series A Led by M Ventures (2024-12-04)
Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 ...
Antag Therapeutics Closes €80m Series A Led by Versant (2024-12-04)
> Round led by Versant Ventures with participation from founding investor Novo Holdings and new investors SR One, Dawn Biopharma and Pictet > Entering Phase I testing for next-generation weight loss therapy by antagonizing GIPR Antag Therapeutics, a next-ge...
ViveBiotech Secures Growth Investment from Ampersand (2024-12-04)
VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO), today announced a growth equity investment from Ampersand Capital Partners (“Ampersand”), a private equity firm specializing in the life sciences and healthcare...

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

» Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]